Target intelligence / Profile preview

RNA, U6 small nuclear 121, pseudogene (RNU6-121P)

Target
RNU6-121P
Molecular classification
Other, Pseudogene, Small nuclear RNA-derived sequence
01

Overview

**RNA, U6 small nuclear 121, pseudogene (RNU6-121P)** is a non-coding RNA gene classified as a pseudogene and is related to the U6 small nuclear RNA family. Pseudogenes like RNU6-121P are **non-functional gene copies** derived from functional genes (in this case, U6 small nuclear RNA) and do not code for functional RNA or protein products. U6 small nuclear RNA itself is a key component of the spliceosome complex essential for pre-mRNA splicing, but pseudogenes such as RNU6-121P *do not contribute to this activity* and are generally considered transcriptionally inactive "genomic fossils." There is no known therapeutic relevance, biological function, or disease association for RNU6-121P. Thus, it is not considered a valid drug target or biomarker[1][4]. **Key notes on correctness and classification:** - The name is correct for a noncoding RNA pseudogene, but this entity is not a therapeutic or functional molecular target[1][4]. - All functional and biomedical relevance relates to the original U6 snRNA, not to pseudogenes like RNU6-121P[2][3]. - There is no evidence for protein product, biological function, interaction with drugs, or disease involvement. - If a true functional target is intended (such as U6 snRNA itself), the query should refer to "U6 spliceosomal RNA" or "U6 small nuclear RNA" instead.

Other names
RNU6-121PRNA, U6 small nuclear 121, pseudogene

Beyond the preview

Go deeper on RNA, U6 small nuclear 121, pseudogene (RNU6-121P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 121, pseudogene (RNU6-121P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call